164 related articles for article (PubMed ID: 14634107)
1. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.
Polgar B; Kispal G; Lachmann M; Paar C; Nagy E; Csere P; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2003 Dec; 171(11):5956-63. PubMed ID: 14634107
[TBL] [Abstract][Full Text] [Related]
2. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production.
Szekeres-Bartho J; Faust Z; Varga P; Szereday L; Kelemen K
Am J Reprod Immunol; 1996 Apr; 35(4):348-51. PubMed ID: 8739452
[TBL] [Abstract][Full Text] [Related]
3. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes.
Szekeres-Bartho J; Faust Z; Varga P
Am J Reprod Immunol; 1995 Dec; 34(6):342-8. PubMed ID: 8607938
[TBL] [Abstract][Full Text] [Related]
4. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
[TBL] [Abstract][Full Text] [Related]
5. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
[TBL] [Abstract][Full Text] [Related]
6. The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions.
Szekeres-Bartho J; Šućurović S; Mulac-Jeričević B
Front Immunol; 2018; 9():2890. PubMed ID: 30619262
[TBL] [Abstract][Full Text] [Related]
7. Progesterone-dependent immunomodulation.
Szekeres-Bartho J; Polgar B; Kozma N; Miko E; Par G; Szereday L; Barakonyi A; Palkovics T; Papp O; Varga P
Chem Immunol Allergy; 2005; 89():118-125. PubMed ID: 16129958
[TBL] [Abstract][Full Text] [Related]
8. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.
Lachmann M; Gelbmann D; Kálmán E; Polgár B; Buschle M; Von Gabain A; Szekeres-Barthó J; Nagy E
Int J Cancer; 2004 Oct; 112(1):51-60. PubMed ID: 15305375
[TBL] [Abstract][Full Text] [Related]
9. PIBF: the double edged sword. Pregnancy and tumor.
Szekeres-Bartho J; Polgar B
Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF).
Ivanova-Todorova E; Kyurkchiev DS; Nalbanski A; Timeva T; Shterev A; Kyurkchiev SD
J Reprod Immunol; 2008 Jul; 78(2):94-101. PubMed ID: 18243332
[TBL] [Abstract][Full Text] [Related]
11. Progesterone induced blocking factor isoforms in normal and failed murine pregnancies.
Bogdan A; Polgar B; Szekeres-Bartho J
Am J Reprod Immunol; 2014 Feb; 71(2):131-6. PubMed ID: 24325791
[TBL] [Abstract][Full Text] [Related]
12. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
Srivastava MD; Thomas A; Srivastava BI; Check JH
Leuk Lymphoma; 2007 Aug; 48(8):1610-7. PubMed ID: 17701593
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production by lymphocytes in pregnancy.
Szereday L; Varga P; Szekeres-Bartho J
Am J Reprod Immunol; 1997 Dec; 38(6):418-22. PubMed ID: 9412725
[TBL] [Abstract][Full Text] [Related]
14. Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity.
Laskarin G; Tokmadzić VS; Strbo N; Bogović T; Szekeres-Bartho J; Randić L; Podack ER; Rukavina D
Am J Reprod Immunol; 2002 Oct; 48(4):201-9. PubMed ID: 12516630
[TBL] [Abstract][Full Text] [Related]
15. Progesterone-induced blocking factor inhibits degranulation of natural killer cells.
Faust Z; Laskarin G; Rukavina D; Szekeres-Bartho J
Am J Reprod Immunol; 1999 Aug; 42(2):71-5. PubMed ID: 10476687
[TBL] [Abstract][Full Text] [Related]
16. Biologia futura: embryo-maternal communication via progesterone-induced blocking factor (PIBF) positive embryo-derived extracellular vesicles. Their role in maternal immunomodulation.
Szekeres-Bartho J; Csabai T; Gorgey E
Biol Futur; 2021 Mar; 72(1):69-74. PubMed ID: 34554496
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress effect on progesterone-induced blocking factor (PIBF) binding to PIBF-receptor in lymphocytes.
de la Haba C; Palacio JR; Palkovics T; Szekeres-Barthó J; Morros A; Martínez P
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):148-57. PubMed ID: 23954806
[TBL] [Abstract][Full Text] [Related]
18. Progesterone-induced blocking factor (PIBF) influences the expression of membrane progesterone receptors (mPRs) on peripheral CD4
Rafiee M; Rezaei A; Alipour R; Sereshki N; Motamedi N; Naseri M
Hormones (Athens); 2021 Sep; 20(3):507-514. PubMed ID: 33914290
[TBL] [Abstract][Full Text] [Related]
19. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor.
Kozma N; Halasz M; Polgar B; Poehlmann TG; Markert UR; Palkovics T; Keszei M; Par G; Kiss K; Szeberenyi J; Grama L; Szekeres-Bartho J
J Immunol; 2006 Jan; 176(2):819-26. PubMed ID: 16393965
[TBL] [Abstract][Full Text] [Related]
20. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
